SCHEMBL4672138

SCHEMBL4672138

CC(C)(C)CC(C)(C)c1ccc(Oc2ccc(N)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.71
RAB9A P51151 3/20 0.71
NPC1 O15118 2/20 0.71
ALDH1A1 P00352 6/20 0.63
HPGD P15428 1/20 0.63
MAPK1 P28482 1/20 0.63
SMN1; SMN2 Q16637 4/20 0.53
CYP3A4 P08684 2/20 0.53
TDP1 Q9NUW8 3/20 0.52
TSHR P16473 2/20 0.52
SHBG P04278 1/20 0.50
TEAD4 Q15561 1/20 0.48
POLB P06746 2/20 0.47
MAOA P21397 2/20 0.45
MAOB P27338 1/20 0.44
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
MITF O75030 1/20 0.42
GAA P10253 1/20 0.42
GFER P55789 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480668 0.90 CYP3A4 (0.61) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL6550540 0.88 SHBG (0.61) MAPTRAB9ANPC1ALDH1A1HPGD
Ethylene Glycol SCHEMBL1832016 0.83 CYP3A4 (0.69) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL10435899 0.83 CYP3A4 (0.54) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL15054796 0.83 MAPT (1.00) MAPTRAB9ANPC1ALDH1A1HPGD
Oxirane SCHEMBL28748999 0.81 CYP3A4 (0.53) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL15054998 0.81 KDM4E (0.71) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL31247993 0.81 KDM4E (0.71) MAPTRAB9ANPC1ALDH1A1HPGD
1,4-Butanediol SCHEMBL1592411 0.80 CYP3A4 (0.65) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL20883388 0.79 MAPT (0.47) MAPTRAB9ANPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054881-B1 NOVEL SULFONAMIDE SUBSTITUTED CHROMAN DERIVATIVES USEFUL AS BETA-3 ADRENORECEPTOR AGONISTS BAYER CORP (US) 2008-07-30 EP disclosed
US-6051586-A HYPOGLYCEMIC AGENTS; ANTIDIABETIC AGENTS BAYER CORPORATION (US) 2000-04-18 US disclosed
US-3997519-A Method of producing quaternary pyridinium compounds GAF CORPORATION (US) 1976-12-14 US disclosed